Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 20, Issue Suppl 1
DGI-017 Bevacizumab Plus Irinotecan in Malignant Gliomas
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Drug information (i. anti-infectives, ii. cytostatics, iii. others)
DGI-017 Bevacizumab Plus Irinotecan in Malignant Gliomas
Free
Online download statistics by month:
Online download statistics by month: March 2013 to March 2024
Abstract
Full
Pdf
Mar 2013
9
0
3
Apr 2013
2
0
1
May 2013
8
0
2
Jun 2013
8
0
0
Jul 2013
0
0
1
Aug 2013
2
0
1
Sep 2013
1
0
0
Nov 2013
4
0
0
Dec 2013
13
1
0
Jan 2014
3
0
0
Feb 2014
1
0
0
Apr 2014
2
0
0
May 2014
1
0
0
Jun 2014
1
0
0
Jul 2014
4
0
0
Aug 2014
2
2
0
Oct 2014
1
0
1
Nov 2014
2
0
0
Dec 2014
5
0
0
Jan 2015
3
0
1
Feb 2015
1
0
0
Mar 2015
4
0
1
Apr 2015
5
0
0
May 2015
1
0
0
Jul 2015
4
0
2
Aug 2015
1
0
0
Sep 2015
5
0
0
Oct 2015
1
0
0
Dec 2015
12
0
1
Jan 2016
10
0
2
Feb 2016
6
0
0
Jun 2016
1
0
3
Jul 2016
3
0
3
Aug 2016
2
0
2
Sep 2016
6
0
2
Oct 2016
2
0
1
Nov 2016
4
0
1
Dec 2016
5
0
0
Jan 2017
10
0
0
Feb 2017
5
0
0
Mar 2017
3
0
0
Apr 2017
3
0
0
May 2017
2
0
0
Jun 2017
2
0
0
Jul 2017
6
0
0
Aug 2017
12
0
0
Sep 2017
10
0
0
Oct 2017
18
0
0
Nov 2017
10
0
0
Dec 2017
18
0
1
Jan 2018
52
0
0
Feb 2018
42
0
0
Mar 2018
36
0
0
Apr 2018
20
0
0
May 2018
34
0
4
Jun 2018
22
0
0
Jul 2018
16
0
1
Aug 2018
12
0
0
Sep 2018
4
0
0
Oct 2018
4
0
0
Nov 2018
10
0
0
Dec 2018
16
0
0
Jan 2019
10
0
0
Feb 2019
2
0
1
Mar 2019
6
0
2
Apr 2019
4
0
1
May 2019
2
0
2
Jun 2019
0
0
1
Jul 2019
2
0
2
Aug 2019
2
0
2
Sep 2019
4
0
3
Oct 2019
0
0
1
Nov 2019
4
0
3
Dec 2019
0
0
1
Jan 2020
4
0
3
Feb 2020
8
0
1
Mar 2020
0
0
2
Apr 2020
4
0
2
May 2020
4
0
4
Jun 2020
6
0
0
Jul 2020
10
0
5
Aug 2020
2
0
1
Sep 2020
10
0
3
Oct 2020
6
0
1
Nov 2020
12
0
5
Dec 2020
4
0
4
Jan 2021
8
0
6
Feb 2021
15
0
4
Mar 2021
6
0
4
Apr 2021
10
0
3
May 2021
6
0
1
Jun 2021
0
0
1
Jul 2021
0
0
6
Aug 2021
0
0
5
Sep 2021
0
0
3
Oct 2021
4
0
14
Nov 2021
14
0
14
Dec 2021
4
0
7
Jan 2022
4
0
2
Feb 2022
2
0
0
Mar 2022
6
0
3
Apr 2022
14
0
0
May 2022
14
0
11
Jun 2022
42
0
4
Jul 2022
4
0
2
Aug 2022
4
0
5
Sep 2022
4
0
6
Oct 2022
18
0
2
Nov 2022
6
0
3
Dec 2022
12
0
0
Jan 2023
4
0
3
Feb 2023
4
0
1
Mar 2023
2
0
0
Apr 2023
4
0
4
May 2023
0
0
5
Jun 2023
2
0
0
Jul 2023
6
0
4
Aug 2023
5
0
30
Sep 2023
4
0
12
Oct 2023
30
0
4
Nov 2023
16
0
0
Dec 2023
16
0
2
Jan 2024
14
0
5
Feb 2024
12
0
2
Mar 2024
10
0
23
Total
944
3
285
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF